BCL9L and neoplasm: Consistently, the high expression of BCL9L in tumor tissues was correlated with a poorer prognosis of patients with melanoma, breast cancer, and other cancer types such as pancreatic cancer, lung cancer, and liver cancer (Figs 6F and EV5J).